Do you want to link to our other external sites and leave Amgen.ca?
You are now leaving the Amgen Canada website. Please note that the information you are about to view may not comply with Canadian regulatory requirements. Marketing authorizations and availability of products may differ between Canada and other countries.
You are now leaving the Amgen.ca website.
The linked sites are not under the control of Amgen, and Amgen is not responsible for the content available on the linked sites. Such links do not imply Amgen's endorsement of material on any other site, and Amgen disclaims all liability with regard to your access to such linked websites. Amgen provides links to other Internet sites as a convenience to users, and access to such linked sites is at your own risk
Amgen is one of the world's leading biotechnology companies, present in more than 100 countries and with a global team of 23,000 employees.
With a 40-year history, the company was created to unlock scientific knowledge about biology and drive significant advances in health. That founding principle identifies us as a company strongly grounded in science and focused on substantially improving the quality of life for patients with serious illnesses around the world.
Amgen uses the best of biology and technology to fight the world’s toughest diseases—such as cancer, heart disease, asthma, and osteoporosis—and help make life easier, fuller, and longer for millions of people globally. With roots in the biotech revolution, Amgen is one of the world’s leading independent biotech companies.
Find out why Amgen operates at a different rhythm, accelerating the pace of change at the cutting edge of medical discovery, inventing powerful new therapies and reliably delivering them to patients.
The rhythm of life unfolds at an ever-changing pace. Some moments pass in a blur. Others tick by in slow motion.
But no matter what the pace of life, nothing is more valuable than the time we have to experience it—and the chance we have to live each moment to its fullest.
That’s why Amgen operates at a different rhythm, moving quickly toward the future by combatting the world’s toughest diseases.
With roots in the biotech revolution, today Amgen is one of the world’s leading independent biotech companies.
With each decade, we stay on the cutting edge of medical discovery, inventing powerful therapies—and reliably delivering them to patients.
We fight the toughest diseases, such as cancer, heart disease, asthma, and osteoporosis to help millions of people globally.
We live in a new era of human health. And Amgen continues to accelerate the pace of change--operating sustainably and drawing upon our deep knowledge of science to push beyond what’s known today.
We tap into a vast library of human and genetic data to unearth new insights into treating disease.
We are creating new therapies that are more precise and personalized than ever before, advancing medicines that can work in new ways, such as targeting multiple pathways in the body at the same time.
Machine learning and artificial intelligence help us make medicines more quickly and effectively by helping to predict if they’ll be safe and effective.
We’re also removing barriers that limit equitable access to healthcare to make our medicines available to more patients around the world.
At Amgen, our mission is to serve patients because we want these rhythms of life to continue. We want you, and your loved ones, to make every moment count—and to count on having more moments.
Amgen was one of the pioneering companies in the use of living cells to manufacture biological medicines, opening the way to the field of biotechnology: we created and gave visibility to the scientific and productive procedures that turned biotechnology into a source of therapies for patients. Worldwide.
At Amgen we develop innovative medicines for significant unmet medical needs focused on several therapeutic areas: oncology, hematology, bone health, inflammation, cardiovascular disease, neurology, and nephrology.
We have a robust portfolio of innovative medicines, and important projects underway, to lead the next generation in bio-manufacturing. Our research focuses on the study of innovative molecules, new indications for various drugs and biosimilar treatments.